NJ State Employees Deferred Compensation Plan - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 105 filers reported holding ARATANA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$568,000
+125.4%
110,000
+57.1%
0.10%
+121.7%
Q1 2019$252,000
+37.0%
70,000
+133.3%
0.05%
+21.1%
Q4 2018$184,000
-82.0%
30,000
-82.9%
0.04%
-78.2%
Q3 2018$1,022,000
+33.6%
175,000
-2.8%
0.17%
+27.0%
Q2 2018$765,000
+2.0%
180,000
+5.9%
0.14%
+2.2%
Q1 2018$750,000
+1.9%
170,000
+21.4%
0.13%
+5.5%
Q4 2017$736,000140,0000.13%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Engaged Capital LLC 3,487,149$21,376,0003.96%
Broadfin Capital, LLC 4,083,135$25,030,0003.29%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0001.30%
GENERAL AMERICAN INVESTORS CO INC 1,599,365$9,804,0001.03%
Grandeur Peak Global Advisors, LLC 821,038$5,033,0000.65%
CADENCE CAPITAL MANAGEMENT LLC 307,294$1,884,0000.19%
Redmond Asset Management, LLC 60,176$369,0000.18%
Alambic Investment Management, L.P. 65,000$398,0000.17%
MENTA CAPITAL LLC 39,562$243,0000.09%
Campbell & CO Investment Adviser LLC 12,990$88,0000.09%
View complete list of ARATANA THERAPEUTICS INC shareholders